(Q39614881)

24725942

13 September 2017

title

Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus (English)

1 reference

13 September 2017

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Fumihiko Yasui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michinori Kohara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Masahiro Kitabatake

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Tetsu Nishiwaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Hideki Fujii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Chise Tateno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Misako Yoneda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kouichi Morita

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kouji Matsushima

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Chieko Kai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

4 March 2014

1 reference

13 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

454-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

157-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

Characterization of CD4(+) CTLs ex vivo

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Critically ill patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Blood monocytes consist of two principal subsets with distinct migratory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Neutralizing antibody response and SARS severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

An interferon-gamma-related cytokine storm in SARS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

A major outbreak of severe acute respiratory syndrome in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

T cell responses to whole SARS coronavirus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Lung pathology of fatal severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

The severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Severe acute respiratory syndrome in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Origins and tissue-context-dependent fates of blood monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.02.005

The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24725942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.02.005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

24725942

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24725942%20AND%20SRC:MED&resulttype=core&format=json